Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: A prediction model study

Xiaochen Fei,Xinxing Du,Jiayi Wang,Jiazhou Liu,Yiming Gong,Zejun Zhao,Zhibin Cao,Qibo Fu,Yinjie Zhu,Liang Dong,Baijun Dong,Jiahua Pan,Wenshe Sun,Shaowei Xie,Wei Xue

DOI: https://doi.org/10.1097/js9.0000000000001033

2024-01-04

International Journal of Surgery

Abstract:Objectives: Prostate cancer (PCa) is one of the most common malignancies in men worldwide and has caused increasing clinical morbidity and mortality, making timely diagnosis and accurate staging crucial. We introduced a novel approach based on mass spectrometry (MS) for precise diagnosis and stratification of PCa to facilitate clinical decision-making. Methods: Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) MS analysis of trace blood samples was combined with machine learning algorithms to construct diagnostic and stratification models. A total of 367 subjects, comprising 181 with PCa and 186 with non-PCa were enrolled. Additional 60 subjects, comprising 30 with PCa and 30 with non-PCa were enrolled as an external cohort for validation. Subsequent metabolomic analysis was carried out using Autoflex MALDI-TOF, and the mass spectra were introduced into various algorithms to construct different models. Results: Serum metabolic fingerprints were successfully obtained from 181 patients with PCa and 186 patients with non-PCa. The diagnostic model based on the eight signals demonstrated a remarkable area under curve (AUC) of 100% and was validated in the external cohort with the AUC of 87.3%. Fifteen signals were selected for enrichment analysis, revealing the potential metabolic pathways that facilitate tumorigenesis. Furthermore, the stage prediction model with an overall accuracy of 85.9% precisely classified subjects with localized disease and those with metastasis. The risk stratification model, with an overall accuracy of 89.6%, precisely classified the subjects as low-risk and high-risk. Conclusions: Our study facilitated the timely diagnosis and risk stratification of PCa and provided new insights into the underlying mechanisms of metabolic alterations in PCa.

surgery